In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit

Journal of Antimicrobial Chemotherapy

Volumn 21, Issue 4, 1988, Pages 417-424

  Moore, E P ^a   Speller, D C E ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; NETILMICIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BREAST SURGERY; ENDOCARDITIS; HOSPITAL INFECTION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS;

CARDIAC SURGICAL PROCEDURES; COAGULASE; CORONARY CARE UNITS; DRUG RESISTANCE, MICROBIAL; ENDOCARDITIS, BACTERIAL; GLYCOPEPTIDES; HUMAN; IN VITRO; NETILMICIN; PERSONNEL, HOSPITAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; SUPPORT, NON-U.S. GOV'T; TEICOPLANIN; VANCOMYCIN;

EID: 0023885814     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/21.4.417     Document Type: Article

References (28)

1. Arioli, V. & Pallanza, R. (1987). Teicoplanin-resistant coagulase-negative staphylococci. Lancet 1, 39.
2. Bauemfeind, A. & Peterm uller, C. (1982). In vitro activity of tdchomydn A2 in comparison with penicillin and vancomycin against Gram-positive cocci. European Journal of ClinicalMicrobiology 1, 278-81.
3. Bernard, J.-P., Francioli, P. & Glauser, M. P. (1981). Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing. Journalof Clinical Investigation 68, 1113-6.
4. Brumfitt, W., Hamilton-Miller, J. M. T. & Neville, L. O. (1987). Teicoplanin-resistant coagulase-negative staphylococci. Lancet 1, 328.
5. CuDiford, A. T., Cunningham, J. N., Zeff, R. H., Isom, O. W., Teiko, P. & Spencer, F. C. (1976). Sternal and costochondral infections following open-heart surgery: a review of 2, 594cases. Journal of Thoracic and Cardiovascular Surgery 72, 714-26.
6. Del Bene, V. E., John, J. F., Twitty, J. A. & Lewis, J. W. (1986). Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methidllinresistance. Journal of Infectious Diseases 154, 349-52.
7. Du rack, D. T. & Petersdorf, R. G. (1973). Chemotherapy of experimental staphylococcal endocarditis. L Comparison of commonly recommended prophylactic regimens. Journal ofClinical Investigation 52, 592-8.
8. Fainstein, V., Le Blanc, B. & Bodey, G. P. (1983). Comparative in vitro study of teicomydn Aa. Antimicrobial Agents and Chemotherapy 23, 497-9.
9. Farrington, M. (1986). The prevention of wound infection after coronary artery bypass surgery. Journal of Antimicrobial Chemotherapy 18, 656-9.
10. Felmingham, D., Solomonides, K., O’Hare, M. D., Wilson, A. P. R. & Gruneberg, R. N. (1987). The effect of medium and inoculum on the activity of vancomycin and teicoplanin againstcoagulase-negative staphylococd. Journal of Antimicrobial Chemotherapy 20, 609-10.
11. Grant, A. C., Lacey, R. W., Brownjohn, A. M. & Tumey, J. H. (1986). Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 2, 1166-77.
12. Gruneberg, R. N., Ridgway, G. L., Cremcr, A. W. F. & Fehningham, D. (1983). The sensitivity of Gram-positive pathogens to teichomycin and vancomycin. Drugs under Experimental andClinical Research 9, 139—41.
13. Harding, I. & Garaud, J.-J. (1988). Teicoplanin in the treatment of infections caused by coagulase-negadve staphylococci. Journal of Antimicrobial Chemotherapy, 21, Suppl. A, 93-103.
14. Karchmer, A. W. (1984). Treatment of prosthetic valve endocarditis. In Contemporary Issues in Infectious Diseases, Vol. 2. Endocarditis (Sande, M. A., Kaye, D. & Root, R. K., Eds), pp.165—7. Churchill Livingstone.
15. Karchmer, A. W., Archer, G. L. & Dismukes, W. E. (1983). Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.Annals of Internal Medicine 98, 447-55.
16. Masur, H. & Johnson, W. D. (1980). Prosthetic valve endocarditis. Journal of Thoracic and Cardiovascular Surgery 80, 31-7.
17. McNulty, C. A. M., Garden, G. M. F., Wise, R. & Andrews, J. M. (1985). The pharmacokinetics and tissue penetration of teicoplanin. Journal of AntimicrobialChemotherapy 16, 743-9.
18. Newsom, S. W. B. (1978). Antibiotic prophylaxis for open-heart surgery. Journal of Antimicrobial Chemotherapy 4, 389-91.
19. Peters, G. & Pulverer, G. (1983). Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin. Journal of Antimicrobial Chemotherapy 11, 94-5.
20. Richardson, J. F. & Marples, R. R. (1982). Changing resistance to antimicrobial drugs, and resistance typing in clinically significant strains of Staphylococcus epidermidis. Journal ofMedical Microbiology 15, 475-84.
21. Scheld, W. M., Zak, O., Vosbeck, K. & Sande, M. A. (1981). Bacterial adhesion in the pathogenesis of infective endocarditis: effect of subinhibitory antibiotic concentrations onstreptococcal adhesion in vitro and the development of endocarditis in rabbits. Journal ofClinical Investigation 68, 1381-4.
22. Slaughter, L., Morris, J. E. & Starr, A. (1973) Prosthetic valvular endocarditis: a 12-year review. Circulation 41, 1319-26.
23. Stokes, E. J. & Ridgway, G. L. (1980). Antibacterial drugs. In Clinical Bacteriology, 5th edn, pp. 205-26. Edward Arnold, London.
24. Traina, G. L. & Bonati, M. (1984). Pharmacokinetics of teicoplanin in man after intravenous administration. Journal of Pharmacokinetics and Biophahnaceutics 12, 119-28.
25. Varaldo, P. E., Debbia, E. & Schito, G. C. (1983). In vitro activity of teichomycin and vancomycin alone and in combination with rifampidn. Antimicrobial Agents andChemotherapy 23, 402-6.
26. Verbist, L., Tjandramaga, B., Hendrickx, B., Van Hecken, A., Van Melle, P., Verbesselt, R., et al. (1984). In vitro activity and human pharmacokinetics of teicoplanin. AntimicrobialAgents and Chemotherapy 26, 881-6.
27. Wilson, A. P. R., O’Hare, M. D., Felmingham, D. & Gruneberg, R. N. (1986). Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 2, 973.
28. Wilson, A. P. R., Gruneberg, R. N., Treasure, T. & Sturridge, M. F. (1987). Teicoplanin in the antibiotic prophylaxis of cardiac surgery. Third European Congress of Clinical Microbiology, The Hague, p. 147. Abstract 313.